NCT00161954View on ClinicalTrials.gov

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2004

Study Completion Date

May 31, 2004

Conditions
Encephalitis, Tick-borne
Interventions
BIOLOGICAL

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Trial Locations (1)

2060

SGS Biopharma Research Unit Stuivenberg, Antwerp

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY